Clinical Study

Efficacy and Tolerability of Malartin and Sulphadoxine-Pyrimethamine Combination against Uncomplicated Falciparum Malaria in Dibanda, Southwest Cameroon

Table 1

Baseline characteristics of patients attending Cameroon Christian Medical Foundation (CAMEF) during the in vivo study, 2007-2008.

CharacteristicValue

Number of study subjects174
Sex ratio (male/female ratio)74/100
Age (median)11.4
Age of males (median)11.8
Age of females (median)10.9
Body weight (kg) (mean ± SD) 4 0 . 4 0 ± 2 1 . 9 0 (9–95)*
Initial body temperature (°C) (mean ± SD) 3 7 . 9 1 ± 0 . 9 3 (36–40)*
Haematocrit (%) (mean ± SD) 3 4 . 2 7 ± 5 . 6 4 (13–50)*
% anaemic (PCV < 31%)22.99% (40/174)
Geometric mean parasite density 4 3 3 8 ± 1 1 7 2 5 (1000–104000)*

* Indicates the range. SD = standard deviation.